EB Research Grants 2025/26 · Open Call for Applications

DEBRA Australia is pleased to call for applications for new research funding for projects aimed at improving the health and wellbeing of children and adults with Epidermolysis Bullosa (EB).

Two research grants will be offered:

  • One to the value of up to $50,000 for a principal investigator who is an established researcher
  • One to the value of up to $30,000 to an early career researcher who is less than 7 years post PhD at the time of application

Both grants will be offered over a 1-year period (2026). It is planned that decisions on funding from this call will be notified at the end of 2025 or early 2026.

Our Research Priorities, which are aligned with the priorities of DEBRA International and EB Resnet, are:

  1. Improving understanding of EB biology to create new concepts for diagnosis and treatment.
  2. Developing EB disease-modifying and curative therapies.
  3. Preventing and curing severe EB disease consequences: chronic wounds, fibrosis, and cancer.
  4. Improving clinical care and symptom relief in EB through research.

As DEBRA Australia is keen to create a more robust and collaborative EB research environment in Australia, projects which involve Australian or international collaboration are encouraged.

The deadline for the grant application submission is 5pm EDST, 20 October 2025.

EB Research Pipetting Syringes

For further information, please view our Research Grant Application Guidelines. Applicants are strongly encouraged to study the application guidelines, terms and conditions carefully before preparing their application.

For any Grant-related queries, please get in touch using our Contact Us page.

Our Previous Grants Recipients page details successful Research and Travel Grant applications from 2017 onwards.